suggests

New research is suggesting potential links between GLP-1 drugs and lower risks for some cancers. The recent findings come as semaglutide becomes more available and as prices drop, with generic versions starting to hit Canadian pharmacies this year. The new research was presented alongside more than two dozen other studies at the American Society of…